SII chairman Cyrus Poonawalla says booster dose of Covishield desirable

The ideal gap between two doses of Covishield is two months and another dose of the vaccine should be taken after six months, the Serum Institute of India (SII) chairman Cyrus Poonawalla said here on Friday.

Asked about a report in the medical journal Lancet that antibodies against coronavirus created by Covishield, the vaccine manufactured by the SII, decrease after some time, Poonawalla told reporters that it was true that the antibodies decrease, but “memory cells” remain.

“After six months, the antibodies go down and that is why I have taken the third dose. We have given the third dose to our seven to eight thousand SII employees. For those who have completed the second dose, it is my request to take a booster dose (third dose) after six months,” he said.

He was speaking at a press conference after receiving the prestigious Lokmanya Tilak award here. The ideal gap between two doses of Covishield is two months, he said. “Since there was a shortage of vaccine, the Modi government changed it to three months, but a two-month gap is ideal,” Poonawalla said. He also said that lockdown was not an effective way to deal with the virus.

“Because if there is no lockdown, the disease will be there in the beginning but later the herd immunity will prevail. Why I prefer herd immunity is because the death rate (due to coronavirus) is very low. Lockdown is a good option when the death rate is high,” he said.

In most cases deaths were caused by negligence and delay in reporting the infection to doctors, he claimed.

  • Related Posts

    Maharashtra FDA appoints 34 lab personnel for its Mumbai based drug testing lab

    Mumbai:  As part of strengthening of manpower in labs in Maharashtra, the Maharashtra Food and Drug Administration (FDA) has given appointment orders to 34 lab personnel for its Mumbai based…

    Ayush export declines by 7.4% in first nine months of FY 26

    New Delhi:  Exports of Ayush and herbal products have reported a decline of 7.42% during the first nine months of the fiscal year 2025-26, compared to the same period of…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Maharashtra FDA appoints 34 lab personnel for its Mumbai based drug testing lab

    Maharashtra FDA appoints 34 lab personnel for its Mumbai based drug testing lab

    Ayush export declines by 7.4% in first nine months of FY 26

    Ayush export declines by 7.4% in first nine months of FY 26

    Three State Drug Testing Laboratories Functional in Jammu Kashmir: GoI

    Three State Drug Testing Laboratories Functional in Jammu Kashmir: GoI

    One more illegal drug manufacturing factory busted in Gaya, 9th Kingpin Nabbed amid Massive Seizure

    One more illegal drug manufacturing factory busted in Gaya, 9th Kingpin Nabbed amid Massive Seizure

    ICMR mandates clinical trials to focus on Indian demography, lifestyle

    ICMR mandates clinical trials to focus on Indian demography, lifestyle

    India’s Medical Devices Market Is Set To Hit $50 Billion By 2030: Rubix Report

    India’s Medical Devices Market Is Set To Hit $50 Billion By 2030: Rubix Report